Home / Anti-infectives / Hepatitis B, Purified Antigen
ATC J07BC01 · Vaccines
Hepatitis B, Purified Antigen shortage
As of 31 Oct 2026, Hepatitis B, Purified Antigen has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 2 products.
Countries2/5
Products2packs or presentations
Short since27 Aug 20262 months ago
Earliest return21 Dec 2026company estimate
No return date1products
Main reasonIncreased demand
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | ENGERIX B | GLAXOSMITHKLINE BIOLOGICALS S.A. | 27 Aug 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| BE | Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml) | GlaxoSmithKline Biologicals | 13 Oct 2026 | 21 Dec 2026 | Manufacturing problem Delay in the release of the end product |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.